Zealand Pharma A/S (ZLDPF)
Zealand Pharma A/S Statistics
Share Statistics
Zealand Pharma A/S has 70.68M shares outstanding. The number of shares has increased by 13.4% in one year.
| Shares Outstanding | 70.68M |
| Shares Change (YoY) | 13.4% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 63M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 1.39M, so 1.97% of the outstanding shares have been sold short.
| Short Interest | 1.39M |
| Short % of Shares Out | 1.97% |
| Short % of Float | 3.17% |
| Short Ratio (days to cover) | 628.11 |
Valuation Ratios
The PE ratio is -45.4 and the forward PE ratio is null. Zealand Pharma A/S's PEG ratio is -1.49.
| PE Ratio | -45.4 |
| Forward PE | n/a |
| PS Ratio | 781.31 |
| Forward PS | n/a |
| PB Ratio | 5.68 |
| P/FCF Ratio | -51.89 |
| PEG Ratio | -1.49 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Zealand Pharma A/S.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.14, with a Debt / Equity ratio of 0.05.
| Current Ratio | 21.14 |
| Quick Ratio | 21.11 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | -0.38 |
| Debt / FCF | -0.42 |
| Interest Coverage | -37.37 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $187.14K |
| Profits Per Employee | $-3.22M |
| Employee Count | 335 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.74 |
Taxes
| Income Tax | -4.62M |
| Effective Tax Rate | 0.43% |
Stock Price Statistics
The stock price has increased by -21.23% in the last 52 weeks. The beta is 0.58, so Zealand Pharma A/S's price volatility has been higher than the market average.
| Beta | 0.58 |
| 52-Week Price Change | -21.23% |
| 50-Day Moving Average | 77.05 |
| 200-Day Moving Average | 105.32 |
| Relative Strength Index (RSI) | 54.89 |
| Average Volume (20 Days) | 673 |
Income Statement
In the last 12 months, Zealand Pharma A/S had revenue of 62.69M and earned -1.08B in profits. Earnings per share was -16.24.
| Revenue | 62.69M |
| Gross Profit | 54.82M |
| Operating Income | -1.27B |
| Net Income | -1.08B |
| EBITDA | -1.02B |
| EBIT | -1.05B |
| Earnings Per Share (EPS) | -16.24 |
Balance Sheet
The company has 480.3M in cash and 391.76M in debt, giving a net cash position of 88.55M.
| Cash & Cash Equivalents | 480.3M |
| Total Debt | 391.76M |
| Net Cash | 88.55M |
| Retained Earnings | -6.16B |
| Total Assets | 9.51B |
| Working Capital | 8.12B |
Cash Flow
In the last 12 months, operating cash flow was -930.82M and capital expenditures -13.15M, giving a free cash flow of -943.96M.
| Operating Cash Flow | -930.82M |
| Capital Expenditures | -13.15M |
| Free Cash Flow | -943.96M |
| FCF Per Share | -14.21 |
Margins
Gross margin is 87.44%, with operating and profit margins of -2029.33% and -1720.87%.
| Gross Margin | 87.44% |
| Operating Margin | -2029.33% |
| Pretax Margin | -1728.23% |
| Profit Margin | -1720.87% |
| EBITDA Margin | -1632.69% |
| EBIT Margin | -2029.33% |
| FCF Margin | -1505.74% |
Dividends & Yields
ZLDPF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ZLDPF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 2.89 |
| Piotroski F-Score | 3 |